Works matching IS 15228517 AND DT 2020 AND VI 22 AND IP 11
Results: 25
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1712, doi. 10.1093/neuonc/noaa221
- Publication type:
- Article
Diffusion MRI as an early marker of response to immune checkpoint inhibitors.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1557, doi. 10.1093/neuonc/noaa224
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1564, doi. 10.1093/neuonc/noaa220
- By:
- Publication type:
- Article
SNO 25th anniversary history series: Providing a global platform for communication and exchange in neuro-oncology.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1551, doi. 10.1093/neuonc/noaa219
- By:
- Publication type:
- Article
Separate and not equal: sex differences in JAM-A tumor suppression in glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1555, doi. 10.1093/neuonc/noaa218
- By:
- Publication type:
- Article
Preoperative chemotherapy in medulloblastoma: a change in treatment paradigm?
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1562, doi. 10.1093/neuonc/noaa213
- By:
- Publication type:
- Article
MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1553, doi. 10.1093/neuonc/noaa212
- By:
- Publication type:
- Article
Impact of radiotherapy dosimetric parameters on neurocognitive function in brain tumor patients.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1559, doi. 10.1093/neuonc/noaa208
- By:
- Publication type:
- Article
Response to Letter to Editor.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1706, doi. 10.1093/neuonc/noaa202
- By:
- Publication type:
- Article
DEPOSEIN—how meaningful was the benefit from intrathecal chemotherapy?
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1710, doi. 10.1093/neuonc/noaa195
- By:
- Publication type:
- Article
DEPOSEIN: Take with a grain of salt.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1708, doi. 10.1093/neuonc/noaa181
- By:
- Publication type:
- Article
Letter regarding "Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases".
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1705, doi. 10.1093/neuonc/noaa176
- By:
- Publication type:
- Article
Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO review.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1568, doi. 10.1093/neuonc/noaa149
- By:
- Publication type:
- Article
JAM-A functions as a female microglial tumor suppressor in glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1591, doi. 10.1093/neuonc/noaa148
- By:
- Publication type:
- Article
MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1647, doi. 10.1093/neuonc/noaa140
- By:
- Publication type:
- Article
European genetic ancestry associated with risk of childhood ependymoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1637, doi. 10.1093/neuonc/noaa130
- By:
- Publication type:
- Article
Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1614, doi. 10.1093/neuonc/noaa121
- By:
- Publication type:
- Article
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1667, doi. 10.1093/neuonc/noaa120
- By:
- Publication type:
- Article
Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1696, doi. 10.1093/neuonc/noaa119
- By:
- Publication type:
- Article
HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood–tumor barrier penetration unlinked to a passive marker.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1625, doi. 10.1093/neuonc/noaa118
- By:
- Publication type:
- Article
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1602, doi. 10.1093/neuonc/noaa117
- By:
- Publication type:
- Article
Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1686, doi. 10.1093/neuonc/noaa083
- By:
- Publication type:
- Article
Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1677, doi. 10.1093/neuonc/noaa076
- By:
- Publication type:
- Article
Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1658, doi. 10.1093/neuonc/noaa066
- By:
- Publication type:
- Article
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1580, doi. 10.1093/neuonc/noaa059
- By:
- Publication type:
- Article